House mark for pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; protein used as an erythropoiesis stimulant; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and syringes sold filled with each of the foregoing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith
Pharmaceuticals